Plant ID: NPO9522
Plant Latin Name: Pericopsis angolensis
Taxonomy Genus: Pericopsis
Taxonomy Family: Fabaceae
NCBI TaxonomyDB:
1899197
Plant-of-the-World-Online:
n.a.
Kenya; Tanzania; Rwanda
TSHR; | |
TDP1; ALOX12; GFER; POLB; | |
SYK; | |
PPARA; PPARD; | |
TLR2; | |
TP53; | |
LMNA; NPC1; FABP3; FABP5; FABP2; FABP4; MAPT; GMNN; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | ALOX12 | Arachidonate 12-lipoxygenase | P18054 | CHEMBL3687 |
Enzyme_unclassified | GFER | FAD-linked sulfhydryl oxidase ALR | P55789 | CHEMBL1741189 |
Enzyme_unclassified | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group C | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Kinase | SYK | Tyrosine-protein kinase SYK | P43405 | CHEMBL2599 |
Toll-like and Il-1 receptors | TLR2 | Toll-like receptor 2 | O60603 | CHEMBL4163 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | NPC1 | Niemann-Pick C1 protein | O15118 | CHEMBL1293277 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
Unclassified | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
Unclassified | FABP2 | Fatty acid binding protein intestinal | P12104 | CHEMBL4879 |
Unclassified | FABP4 | Fatty acid binding protein adipocyte | P15090 | CHEMBL2083 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | GMNN | Geminin | O75496 | CHEMBL1293278 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 1.101E-08 | 3.629E-05 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0019433; triglyceride catabolic process | 1.571E-08 | 3.933E-05 | FABP2, FABP3, FABP4, FABP5 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 1.531E-07 | 1.389E-04 | CYP1A1, CYP1A2, CYP1B1 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.823E-07 | 1.527E-04 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 8.607E-07 | 5.355E-04 | ALOX12, CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0050896; response to stimulus | GO:0055093; response to hyperoxia | 1.683E-06 | 8.945E-04 | CYP1A1, POLB, TP53 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 1.683E-06 | 8.945E-04 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0009404; toxin metabolic process | 2.238E-06 | 1.083E-03 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0006691; leukotriene metabolic process | 5.646E-06 | 2.157E-03 | ALOX12, SYK, TLR2 |
BP | GO:0008152; metabolic process | GO:0018894; dibenzo-p-dioxin metabolic process | 7.420E-06 | 2.650E-03 | CYP1A1, CYP1A2 |
BP | GO:0050896; response to stimulus | GO:0042493; response to drug | 1.181E-05 | 3.840E-03 | CYP1A1, CYP1B1, FABP3, NPC1, POLB, TLR2, TP53 |
BP | GO:0008152; metabolic process | GO:0016125; sterol metabolic process | 1.227E-05 | 3.872E-03 | CYP19A1, CYP1B1, NPC1, PPARD |
MF | GO:0005488; binding | GO:0020037; heme binding | 1.227E-05 | 3.872E-03 | CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0050896; response to stimulus | GO:0010038; response to metal ion | 2.489E-05 | 6.948E-03 | CYP1A1, CYP1A2, FABP4, NPC1, TP53 |
MF | GO:0005488; binding | GO:0097371; MDM2/MDM4 family protein binding | 2.591E-05 | 7.008E-03 | PPARA, TP53 |
MF | GO:0005488; binding | GO:0019902; phosphatase binding | 3.252E-05 | 8.636E-03 | MAPT, PPARA, SYK, TP53 |
BP | GO:0008152; metabolic process | GO:0050665; hydrogen peroxide biosynthetic process | 3.453E-05 | 9.059E-03 | CYP1A1, CYP1A2 |
BP | GO:0008152; metabolic process | GO:2000377; regulation of reactive oxygen species metabolic process | 3.658E-05 | 9.481E-03 | CYP1B1, MAPT, SYK, TP53 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 9.644E-11 | 8.294E-09 | FABP2, FABP3, FABP4, FABP5, PPARA, PPARD |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 4.479E-07 | 1.926E-05 | CYP1A2, CYP1A1, CYP1B1, CYP19A1 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 1.112E-05 | 3.187E-04 | CYP1A2, CYP1A1, CYP1B1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 2.190E-05 | 4.708E-04 | CYP1A1, CYP1B1, CYP19A1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 6.835E-05 | 1.176E-03 | CYP1A2, CYP1A1, CYP1B1 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 9.670E-05 | 1.386E-03 | CYP1A2, CYP1A1, CYP1B1 |
09160 Human Diseases | 09161 Cancers | hsa05203 | Viral carcinogenesis | 1.415E-03 | 1.739E-02 | POLB, SYK, TP53 |
09150 Organismal Systems | 09152 Endocrine system | hsa04923 | Regulation of lipolysis in adipocytes | 1.716E-03 | 1.845E-02 | FABP4, TSHR |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 2.304E-03 | 2.201E-02 | CYP1A2, CYP1A1 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 5.488E-03 | 4.651E-02 | CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Hormonally-responsive breast cancer | C50 | CYP19A1; |
N00-N99: Diseases of the genitourinary system | Endometriosis | N80 | CYP19A1; |
N00-N99: Diseases of the genitourinary system | Prostate disease | N42.9 | CYP19A1; |
C00-D49: Neoplasms | Bladder cancer | C67 | CYP19A1; |
C00-D49: Neoplasms | Breast cancer | C50 | CYP19A1; |
C00-D49: Neoplasms | Advanced breast cancer | C50 | CYP19A1; |